Hepatic Encephalopathy
📧 Sign up to get email alerts when something new happens for Hepatic Encephalopathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-04-05Clinical Trial Update: Effectiveness of Oral Lactulose Versus Lactulose Enema in Hepatic Encephalopathy [Phase 4]
Phase 4 trial update evaluating the effectiveness of oral lactulose versus lactulose enema in hepatic encephalopathy.
-
CLINICAL_TRIALS trial_result · 2022-06-10Clinical Trial Update: Fecal Transplant for Hepatic Encephalopathy [Phase 1, Phase 2]
Clinical trial update for fecal transplant in hepatic encephalopathy reporting completed phases 1 and 2.
-
CLINICAL_TRIALS trial_result · 2022-05-31Clinical Trial Update: HEAL STUDY (Hepatic Encephalopathy and Albumin Study) [Phase 2]
Phase 2 clinical trial update for HEAL STUDY investigating hepatic encephalopathy and albumin in cirrhosis; trial status completed.
-
CLINICAL_TRIALS trial_result · 2021-11-19Clinical Trial Update: Integrated Traditional Chinese and Clinical Medicine for Chronic Hepatitis B and Its Complication [Phase 3]
A Phase 3 clinical trial evaluating integrated traditional Chinese and clinical medicine for chronic hepatitis B and its complications is un…
-
CLINICAL_TRIALS trial_result · 2021-10-04Clinical Trial Update: Fecal Microbiota Transplantation (FMT) in the Management of Hepatic Encephalopathy (HE): a Pilot Study [Phase 1, Phase 2]
A pilot Phase 1/2 clinical trial evaluating fecal microbiota transplantation for hepatic encephalopathy has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-09-16Clinical Trial Update: Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE) [Phase 2]
Phase 2B trial assessing efficacy and safety of Ornithine Phenylacetate in hospitalized patients with hepatic encephalopathy has completed, …
-
CLINICAL_TRIALS trial_result · 2021-07-20Clinical Trial Update: MNK6106 for Liver Disease (Hepatic Cirrhosis) That in the Past Has Affected the Brain (Hepatic Encephalopathy) [Phase 2]
Phase 2 trial update for MNK6106 in hepatic cirrhosis with hepatic encephalopathy (HE) has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-05-10Clinical Trial Update: Efficacy of L-Ornithine L-Aspartate in Acute Hepatic Encephalopathy. [Phase 4]
Phase 4 trial update on the efficacy of L-Ornithine L-Aspartate for hepatic encephalopathy.
-
CLINICAL_TRIALS trial_result · 2021-02-03Clinical Trial Update: Microbial Resistance of Rifaximin in Hepatic Encephalopathy [Phase 4]
Phase 4 trial update on rifaximin for hepatic encephalopathy focusing on microbial resistance.
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: Rifaximin in Minimal Hepatic Encephalopathy [NA]
Clinical trial update for rifaximin in minimal hepatic encephalopathy has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-09-04Clinical Trial Update: Efficacy of Combined Oral L-ornithine-L-aspartate and Lactulose in Patients With Hepatic Encephalopathy [Phase 4]
Phase 4 trial update evaluating the efficacy of combined L-ornithine-L-aspartate with lactulose for hepatic encephalopathy.
-
CLINICAL_TRIALS trial_result · 2020-02-10Clinical Trial Update: A Retrospective, Open-label, Uncontrolled Cohort Study to Assess the Effectiveness and Safety of Lactulose Retention Enema in the Treatment of Cirrhotic Patients With Grade 3 or 4 (West Haven Criteria) Hepatic Encephalopathy (HE) [The RETRO Study]
A retrospective, open-label cohort study evaluating the effectiveness and safety of lactulose retention enema for treating hepatic encephalo…
-
CLINICAL_TRIALS trial_result · 2019-11-13Clinical Trial Update: Efficacy and Safety of Nitazoxanide in Preventing Recurrence of Hepatic Encephalopathy [Phase 3]
Phase 3 trial update on nitazoxanide for preventing recurrence of hepatic encephalopathy focusing on efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2019-09-17Clinical Trial Update: RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy - A Randomized, Controlled Trial [Phase 3]
Phase 3 randomized trial evaluating rifaximin for hepatic encephalopathy; trial terminated with posted results in 2019.
-
CLINICAL_TRIALS trial_result · 2019-09-09Clinical Trial Update: The Safety/Efficacy of Rifaximin With/Without Lactulose in Participants With A History of Recurrent Hepatic Encephalopathy [Phase 4]
Phase 4 trial assessing safety and efficacy of rifaximin with or without lactulose in participants with a history of recurrent hepatic encep…
-
CLINICAL_TRIALS trial_result · 2019-08-14Clinical Trial Update: Safety and Tolerability Study of Rifaximin in Participants With a History of Hepatic Encephalopathy [Phase 3]
Phase 3 safety and tolerability trial of rifaximin in participants with a history of hepatic encephalopathy has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2019-08-14Clinical Trial Update: A 6-month Efficacy, Safety, and Tolerability Study of Rifaximin In Preventing Hepatic Encephalopathy [Phase 3]
A Phase 3 clinical trial evaluating rifaximin for prevention of hepatic encephalopathy reports completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-06-17Clinical Trial Update: PEG3350 in ACLF With Hepatic Encephalopathy [Phase 4]
Clinical trial update for PEG3350 in acute-on-chronic liver failure with hepatic encephalopathy (Phase 4) is ongoing with an unknown status.
-
CLINICAL_TRIALS trial_result · 2019-04-09Clinical Trial Update: Effect of Rifaximine on Sleep Disorders in Patients Suffering From Hepatic Encephalopathy [NA]
Clinical trial updating the effects of rifaximin on sleep disorders in patients with hepatic encephalopathy; study completed with results po…
-
CLINICAL_TRIALS trial_result · 2018-05-22Clinical Trial Update: Lactulose, L-ornithine L-aspartate, or Rifaximin Versus Placebo for Preventing Hepatic Encephalopathy in Variceal Bleeding [Phase 4]
Phase 4 clinical trial comparing lactulose, L-ornithine L-aspartate, and rifaximin against placebo to prevent hepatic encephalopathy in pati…
-
CLINICAL_TRIALS trial_result · 2017-12-28Clinical Trial Update: Albumin Infusion Effects in Mortality in Patients With Cirrhosis and Hepatic Encephalopathy [Phase 4]
Phase 4 trial investigating albumin infusion effects on mortality in patients with cirrhosis and hepatic encephalopathy.
-
CLINICAL_TRIALS trial_result · 2017-08-22Clinical Trial Update: Study on B-blockers to Prevent Decompensation of Cirrhosis With HTPortal [Phase 4]
Phase 4 clinical trial evaluating non-selective beta-blockers to prevent decompensation in cirrhosis with portal hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2017-08-22Clinical Trial Update: Autoregulation Assessment During Liver Transplantation
This is an update of a completed clinical trial evaluating autoregulation during liver transplantation.
-
CLINICAL_TRIALS trial_result · 2017-08-04Clinical Trial Update: The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy. [NA]
Clinical trial evaluating the role of small intestinal bacterial overgrowth and delayed intestinal transit in hepatic encephalopathy; the st…
-
CLINICAL_TRIALS trial_result · 2017-05-11Clinical Trial Update: Feasibility of Critical Flicker Frequency Procedure for the Diagnosis of Minimal Encephalopathy [NA]
This clinical trial update reports on the feasibility of using the critical flicker frequency procedure to diagnose minimal hepatic encephal…